AAAAAA

   
Results: 1-20 |
Results: 20
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
Authors: Kuehl, P Zhang, J Lin, Y Lamba, J Assem, M Schuetz, J Watkins, PB Daly, A Wrighton, SA Hall, SD Maurel, P Relling, M Brimer, C Yasuda, K Venkataramanan, R Strom, S Thummel, K Boguski, MS Schuetz, E
Citation: P. Kuehl et al., Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression, NAT GENET, 27(4), 2001, pp. 383-391
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants
Authors: Zhang, J Kuehl, P Green, ED Touchman, JW Watkins, PB Daly, A Hall, SD Maurel, P Relling, M Brimer, C Yasuda, K Wrighton, SA Hancock, M Kim, RB Strom, S Thummel, K Russell, CG Hudson, JR Schuetz, EG Boguski, MS
Citation: J. Zhang et al., The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants, PHARMACOGEN, 11(7), 2001, pp. 555-572
Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts
Authors: Chalasani, N Gorski, JC Patel, NH Hall, SD Galinsky, RE
Citation: N. Chalasani et al., Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts, HEPATOLOGY, 34(6), 2001, pp. 1103-1108
In vivo effect of clarithromycin on multiple cytochrome P450S
Authors: Bruce, MA Hall, SD Haehner-Daniels, BD Gorski, JC
Citation: Ma. Bruce et al., In vivo effect of clarithromycin on multiple cytochrome P450S, DRUG META D, 29(7), 2001, pp. 1023-1028
In vitro exposure to highly cytopathic HIV-1 X4 strains increases expression of mucosa-associated integrins on CD4(+) T cells
Authors: Cummins, JE Bunn, WJ Hall, SD Donze, HH Mestecky, J Jackson, S
Citation: Je. Cummins et al., In vitro exposure to highly cytopathic HIV-1 X4 strains increases expression of mucosa-associated integrins on CD4(+) T cells, VIROLOGY, 280(2), 2001, pp. 262-272
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity
Authors: Wang, ZQ Gorski, C Hamman, MA Huang, SM Lesko, LJ Hall, SD
Citation: Zq. Wang et al., The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity, CLIN PHARM, 70(4), 2001, pp. 317-326
The effect of rifampin administration on the disposition of fexofenadine
Authors: Hamman, MA Bruce, MA Haehner-Daniels, BD Hall, SD
Citation: Ma. Hamman et al., The effect of rifampin administration on the disposition of fexofenadine, CLIN PHARM, 69(3), 2001, pp. 114-121
Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank
Authors: Fisher, MB VandenBranden, M Findlay, K Burchell, B Thummel, KE Hall, SD Wrighton, SA
Citation: Mb. Fisher et al., Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank, PHARMACOGEN, 10(8), 2000, pp. 727-739
Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin
Authors: Han, Y Ventura, CL Black, KP Cummins, JE Hall, SD Jackson, S
Citation: Y. Han et al., Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin, ORAL MICROB, 15(2), 2000, pp. 82-88
Intravenous diltiazem and CYP3A-mediated metabolism
Authors: Masica, AL Azie, NE Brater, DC Hall, SD Jones, DR
Citation: Al. Masica et al., Intravenous diltiazem and CYP3A-mediated metabolism, BR J CL PH, 50(3), 2000, pp. 273-276
An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4by metabolic intermediate complex formation
Authors: Mayhew, BS Jones, DR Hall, SD
Citation: Bs. Mayhew et al., An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4by metabolic intermediate complex formation, DRUG META D, 28(9), 2000, pp. 1031-1037
The effect of hormone replacement therapy on CYP3A activity
Authors: Gorski, JC Wang, ZQ Heahner-Daniels, BD Wrighton, SA Hall, SD
Citation: Jc. Gorski et al., The effect of hormone replacement therapy on CYP3A activity, CLIN PHARM, 68(4), 2000, pp. 412-417
The interaction of diltiazem with simvastatin
Authors: Mousa, O Brater, DC Sundblad, KJ Hall, SD
Citation: O. Mousa et al., The interaction of diltiazem with simvastatin, CLIN PHARM, 67(3), 2000, pp. 267-274
In vivo effects of interleukin-10 on human cytochrome P450 activity
Authors: Gorski, JC Hall, SD Becker, P Affrime, MB Cutler, DL Haehner-Daniels, B
Citation: Jc. Gorski et al., In vivo effects of interleukin-10 on human cytochrome P450 activity, CLIN PHARM, 67(1), 2000, pp. 32-43
Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases - Comparison of human liver and kidney microsomes and mammalianenzymes
Authors: Hamman, MA Haehner-Daniels, BD Wrighton, SA Rettie, AE Hall, SD
Citation: Ma. Hamman et al., Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases - Comparison of human liver and kidney microsomes and mammalianenzymes, BIOCH PHARM, 60(1), 2000, pp. 7-17
Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination
Authors: Grubb, NG Rudy, DW Brater, DC Hall, SD
Citation: Ng. Grubb et al., Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination, BR J CL PH, 48(4), 1999, pp. 494-500
Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily
Authors: Gorski, JC Jones, DR Hamman, MA Wrighton, SA Hall, SD
Citation: Jc. Gorski et al., Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily, XENOBIOTICA, 29(9), 1999, pp. 931-944
Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation
Authors: Jones, DR Gorski, JC Hamman, MA Mayhew, BS Rider, S Hall, SD
Citation: Dr. Jones et al., Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation, J PHARM EXP, 290(3), 1999, pp. 1116-1125
Autoactivation and activation of the cytochrome P450s
Authors: Ekins, S Ring, BJ Binkley, SN Hall, SD Wrighton, SA
Citation: S. Ekins et al., Autoactivation and activation of the cytochrome P450s, INT J CL PH, 36(12), 1998, pp. 642-651
Analysis of circumferential lumbar fusion outcome in the treatment of degenerative disc disease of the lumbar spine
Authors: Gertzbein, SD Hollopeter, M Hall, SD
Citation: Sd. Gertzbein et al., Analysis of circumferential lumbar fusion outcome in the treatment of degenerative disc disease of the lumbar spine, J SPINAL D, 11(6), 1998, pp. 472-478
Risultati: 1-20 |